Advances in Immunotherapy for Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Patients with GBM have poor outcomes, even with the current gold-standard first-line treatment: maximal safe resection combined with radiotherapy and temozolomide chemotherapy. Accumulating evidence suggests th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunol Res
Hlavní autoři: Huang, Boyuan, Zhang, Hongbo, Gu, Lijuan, Ye, Bainxin, Jian, Zhihong, Stary, Creed, Xiong, Xiaoxing
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2017
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337363/
https://ncbi.nlm.nih.gov/pubmed/28299344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3597613
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky